Improved radiation protection of man requires a better understanding of the mechanisms of radiation action, and improved estimates of radiation risk for both internal and external radiations. The Japanese atomic-bomb survivors represent the most important source of human data on the late carcinogenic effects of ionizing radiation. Current risk estimates for low linear energy transfer (LET) radiations used for the protection of radiation workers and the public, and for patient exposures from medical x-rays, are based mainly on the epidemiological analyses of these survivors. It is often overlooked that these survivors were exposed to high energy gamma-radiations, predominantly > 1MeV. A fundamental assumption implicit in the use of radiation risk estimates derived from the atomic-bomb survivor data is that the atomic-bomb gamma-rays are of equal radiobiological effectiveness (RBE) to the lower energy low-LET radiations commonly encountered in the work place. However, evidence is mounting from cell radiobiology studies that there is an inverse relationship between energy and biological effectiveness. On this basis, radiation risk estimates in excess of those recommended by the ICRP could be justified, particularly for situations involving low energy photon exposures such as in diagnostic mammography or Plutonium handling facilities. Radiobiological data related to the effects of low-LET radiation are however limited. A collaborative European series of radiobiology experiments is planned to produce a consistent data set of RBE values for various end-points, over a wide range of photon energies. These should help to clarify the magnitude of the variation of RBE with LET for low-LET radiations and provide basic input data for the formulation of revised international recommendations. To facilitate this aim the present study was undertaken to investigate the appropriate design of a photon irradiation facility to mimic the spectra encountered in Hiroshima and Nagasaki. The estimated total gamma-ray fluence spectra (including both prompt and delayed photons) at both Hiroshima and Nagasaki, for distances of 500, 1000, 1500, and 2000m, have been evaluated using DS86 data and previously unpublished information for delayed gamma radiations which make a major contribution to survivor doses. Monte Carlo (EGS4) simulations were performed to transport these photons through the body to the colon in order to investigate the variation in photon spectra for various body organs. The spectra obtained for these fluences passing through the colon have been reconstructed from spectra obtained from therapeutic x-ray machines and linear accelerators that are commonly available in Hospitals. Recommendations will be given for cell irradiations, taking into account appropriate phantoms, beam filters and operating potentials. These will, for the first time, enable a direct link to be made between radiobiological studies and the epidemiological data from Japan, which currently underpin radiation risk estimates.
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